CEACAM5 and pancreatic neoplasm: The majority of the top 10 LCS-ranked articles concentrate on the following themes (18, 20–28): (1) The use of specific fluorescent agents, particularly those conjugated with anti-CEA antibodies for tumor targeting, has emerged as a research trend, facilitating fluorescence imaging of pancreatic tumors, including applications in surgical navigation, tumor evaluation, margin assessment, and tumor staging.